The dual PI3K delta/gamma inhibitor, RP6530, in combination with ibrutinib or fludarabine, synergistically enhances cytotoxicity in primary CLL cells in vitro.
- Resource Type
- Journal
- Source
CLINICAL CANCER RESEARCH ; SEP 1 2015, 21 2p. Supplement: 17- Subject
- Language
- English
- ISSN
- 15573265